New approach to targeting STAT3 achieves near complete elimination of leukemia and lymphoma tumors in mouse models.

Researchers devise new approach to find drug-activity biomarkers in fight against triple-negative breast cancer.

New breast implant guidelines proposed by the FDA would require patient decision checklists to aid in patient education.

Cervical cancer screening rates plummet in women 45-65, despite half of all cervical cancer diagnoses occurring in women over 49.

Michigan Medicine research finds one narcotic alternative prescription had a two-fold increase despite unclear evidence of benefit for cancer pain.

Low-risk thyroid cancer patients may not see health benefits from increased testing after surgery.

A Michigan Medicine survey reveals patients could feel more empowered and better understand their diagnosis after speaking directly with a pathologist.

An ovarian cancer diagnosis gave one 26-year-old patient new perspectives on life and adventure.

Prostate cancer patients can now pursue healthy sex lives/sexual relationships after surgery

Michigan Medicine’s Rogel Cancer Center discusses updated recommendations on screening for BRCA1 and BRCA2 genetic mutations.

Christina Chapman, M.D., sits down for a discussion on diversity, equity and inclusion in medicine.

Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.

Guitarist and bladder cancer survivor, Rendal Wall of Kalamazoo, continues to live a life surrounded by music after bladder removal surgery.

Better shared decision-making could help patients feel more empowered, avoid treatment side-effects and reduce overtreatment.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.